XTX Topco’s Arena Pharmaceuticals Inc ARNA Stock Holding History

XTX Topco’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,965	Closed	-$275K	–	1191
2021 Q1	$275K	Buy	+3,965	New	+$305K	0.13%	318

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco's ARNA Position: Q2 2021 in Review

XTX Topco sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2021, closing a stake of 3,965 shares — an estimated $275K sold.

XTX Topco first reported a position in ARNA in Q1 2021 and held it in 1 quarter. The position peaked at $275K in Q1 2021. 237 funds tracked by Wall St. Rank hold ARNA as of Q2 2021.

XTX Topco reported no remaining Arena Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
XTX Topco sold 3,965 Arena Pharmaceuticals Inc shares in Q2 2021, an estimated $275K.
XTX Topco first reported a position in Arena Pharmaceuticals Inc in Q1 2021 and held it in 1 quarter.
XTX Topco's Arena Pharmaceuticals Inc position peaked at $275K in Q1 2021.
237 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2021.

Based on XTX Topco's 13F filing for Q2 2021, filed 12 Aug 2021.